View Archive

Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Pfizer Inc.

Not an official event of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or the Conquer Cancer Foundation.

ASCO: Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting

ASCO: Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting

Sunday, June 3, 2018
7:00 PM - 8:30 PM

Dinner and registration: 6:30 PM – 7:00 PM

Hilton Chicago
Salon A-5 (Lower Level)
720 South Michigan Avenue
Chicago, IL 60605

What You'll Learn:

  • The impact of recent data on current sequencing paradigms
  • Single agent and combination strategies in the adjuvant setting
  • How to weight toxicity management with treatment selection


Renal cell carcinoma (RCC) has been one of most difficult-to-treat of the solid tumors, and more recently, one of the most rapidly evolving fields in oncology. New data suggest impending changes to your practice in both early-stage and metastatic RCC, including novel indications, combination approaches, and optimized adjuvant strategies. The use of adjuvant therapy for RCC remains a hot topic for which high-quality, well-coordinated, multidisciplinary care is of utmost importance to achieving optimal outcomes in the perioperative setting for your patients with RCC.

In this program, a multidisciplinary panel of renowned experts in RCC will guide you through an in-depth, up-to-date review of risk assessment in the earlystage RCC setting, patient selection for adjuvant systemic therapy, evidence from clinical studies of adjuvant therapy for RCC, and overall multidisciplinary care planning. To help you apply this information and to provide you with opportunities to interact with the faculty and each other, this activity includes case-based discussions and a Medical Crossfire® debate on key areas of controversy and clinical uncertainty concerning the use of adjuvant therapy for RCC.

Program Chair:

Robert A. Figlin, MD, FACP
Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Director, Division of Hematology Oncology
Deputy Director, Integrated Oncology Service Line
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, CA

This activity is supported by an educational grant from Pfizer Inc.


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

Please note that attendance is on a first-come, first-served basis. Please arrive early to ensure your spot!

For registration assistance, please email, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.

Click to see all our ASCO programs!

Calendar of Events
Filter By